Amgen Posts Higher Quarterly EPS, Repatha Sales Fall Short

By REUTERS
NYT
Amgen Inc on Tuesday said stock buybacks lifted its third-quarter earnings per share, but operating income fell as expenses rose and sales of some key products declined.
Published date: October 30, 2018 at 11:12PM
Reuters
New York Times article